Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet K Coller

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|August 8, 2013
Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesBenjamin D Noll, Janet K Coller, Andrew A Somogyi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 18, 2013
Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesZaipul I Md Dom, Benjamin D Noll, Janet K Coller, et al.
British Journal of Clinical Pharmacology|September 5, 2002
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
British Journal of Clinical Pharmacology|December 24, 2010
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivationNuala A Helsby, Chung-Yee Hui, Michael A Goldthorpe, et al.
Brain, Behavior, and Immunity|February 1, 2011
Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairmentYue Wu, Erin L Lousberg, Lachlan M Moldenhauer, et al.
Molecular Cancer Therapeutics|August 24, 2016
TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced DiarrheaHannah R Wardill, Joanne M Bowen, Ysabella Z A Van Sebille, et al.
British Journal of Pharmacology|September 30, 2011
Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceYue Wu, Erin L Lousberg, Lachlan M Moldenhauer, et al.
Brain, Behavior, and Immunity|December 28, 2014
Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signalingFrances Corrigan, Yue Wu, Jonathan Tuke, et al.
British Journal of Clinical Pharmacology|February 24, 2015
CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effectsYibai Li, Kate A Jackson, Barry Slon, et al.
Pharmacogenetics and Genomics|April 13, 2007
Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaSally C Inglis, Megan K Herbert, Benjamin J L Davies, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|August 8, 2013
Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesBenjamin D Noll, Janet K Coller, Andrew A Somogyi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 18, 2013
Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesZaipul I Md Dom, Benjamin D Noll, Janet K Coller, et al.
British Journal of Clinical Pharmacology|September 5, 2002
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
British Journal of Clinical Pharmacology|December 24, 2010
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivationNuala A Helsby, Chung-Yee Hui, Michael A Goldthorpe, et al.
Brain, Behavior, and Immunity|February 1, 2011
Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairmentYue Wu, Erin L Lousberg, Lachlan M Moldenhauer, et al.
Molecular Cancer Therapeutics|August 24, 2016
TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced DiarrheaHannah R Wardill, Joanne M Bowen, Ysabella Z A Van Sebille, et al.
British Journal of Pharmacology|September 30, 2011
Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceYue Wu, Erin L Lousberg, Lachlan M Moldenhauer, et al.
Brain, Behavior, and Immunity|December 28, 2014
Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signalingFrances Corrigan, Yue Wu, Jonathan Tuke, et al.
British Journal of Clinical Pharmacology|February 24, 2015
CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effectsYibai Li, Kate A Jackson, Barry Slon, et al.
Pharmacogenetics and Genomics|April 13, 2007
Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaSally C Inglis, Megan K Herbert, Benjamin J L Davies, et al.
Pageof 7